Correlation Between Enliven Therapeutics and PolyPid
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and PolyPid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and PolyPid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and PolyPid, you can compare the effects of market volatilities on Enliven Therapeutics and PolyPid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of PolyPid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and PolyPid.
Diversification Opportunities for Enliven Therapeutics and PolyPid
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and PolyPid is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and PolyPid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PolyPid and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with PolyPid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PolyPid has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and PolyPid go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and PolyPid
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the PolyPid. In addition to that, Enliven Therapeutics is 1.25 times more volatile than PolyPid. It trades about -0.19 of its total potential returns per unit of risk. PolyPid is currently generating about 0.16 per unit of volatility. If you would invest 320.00 in PolyPid on September 1, 2024 and sell it today you would earn a total of 26.00 from holding PolyPid or generate 8.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. PolyPid
Performance |
| Timeline |
| Enliven Therapeutics |
| PolyPid |
Enliven Therapeutics and PolyPid Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and PolyPid
The main advantage of trading using opposite Enliven Therapeutics and PolyPid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, PolyPid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PolyPid will offset losses from the drop in PolyPid's long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| PolyPid vs. Tff Pharmaceuticals | PolyPid vs. Eliem Therapeutics | PolyPid vs. Inhibrx | PolyPid vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |